Resistance to PD-L1/PD-1 Blockade Immunotherapy. A Tumor-Intrinsic or Tumor-Extrinsic Phenomenon?

Resistance to PD-L1/PD-1 Blockade Immunotherapy. A Tumor-Intrinsic or Tumor-Extrinsic Phenomenon?

Cancer immunotherapies targeting immune checkpoints such as programmed cell-death protein 1 (PD-1) and its ligand programmed cell-death 1 ligand 1 (PD-L1), are revolutionizing cancer treatment and transforming the practice of medical oncology. However, despite all the recent successes of this type o...

Full description

Saved in:
Bibliographic Details
Main Authors: Luisa Chocarro de Erauso (Author), Miren Zuazo (Author), Hugo Arasanz (Author), Ana Bocanegra (Author), Carlos Hernandez (Author), Gonzalo Fernandez (Author), Maria Jesus Garcia-Granda (Author), Ester Blanco (Author), Ruth Vera (Author), Grazyna Kochan (Author), David Escors (Author)
Format: Book
Published: Frontiers Media S.A., 2020-04-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items